 aztreonam works Aztreonam first monocyclic beta-lactam antibiotic monobactam synthetic structure determines specific areas activity enhanced activity Pseudomonas species exceptional activity gram-negative bacteria stability beta-lactamases lack activity gram-positive bacteria chemical composition Aztreonam high affinity protein-binding protein aerobic gram-negative bacteria organisms low concentrations drug Aztreonam PBP sites aerobic gram-positive anaerobic bacteria poor inhibitory effects bacteria vitro minimum inhibition concentration MIC values Enterobacteriaceae Neisseria Haemophilus strains microgram milliliter MIC values Pseudomonas aeruginosa micrograms milliliter comparable antipseudomonal beta-lactams acylureidopenicillins combination therapy amino-glycosides aztreonam acts synergy aeruginosa Acinetobacter gentamicin-resistant gram-negative rods Aztreonam body tissues fluids average elimination half-life hours Intramuscular results peak serum levels hour intravenous results peak levels minutes gram dose Enterobacteriaceae hours aeruginosa hours steady-state volume distribution liter kilogram Concentrations gram-negative bacteria present bone prostate cerebrospinal fluid cent drug unchanged urine concentrations micrograms milliliter hours gram dose Serum clearance aztreonam proportional clearance adjustment presence reduced clearance varies grams hours severity infection characteristics aztreonam useful nonnephrotoxic drug treatment aerobic gram-negative infection